PHILADELPHIA, Nov. 16 /PRNewswire/ -- DoseCue, LLC announced this week that medication containers equipped with their automatic dose-time reminder devices significantly increase compliance, or adherence, according to results from a recent study.
The data, which were presented at BioTech 2009 in Philadelphia, showed that DoseCue electronic devices significantly improved patient compliance with oral-dose medications by 9.1%, without adding steps or changing the patient's dose-taking routine. In addition, overall compliance averaged 97.1% in the Study Group in Phase 2.
"This represents an important 'first'," stated DoseCue CEO, Mark Burrows. "The DoseCue trial is the first of its kind to achieve a statistically significant improvement in compliance using this one-of-a-kind, patented technology," he added, noting 95% Confidence Interval.
DoseCue's patented technology is integrated directly into manufacturers' current containers during filling and issues automatic reminder cues to patients when a medication needs to be dosed and signals when the dose has been taken. Electronics are integrated into the medication container itself, not the closure, to avoid mix-up and help differentiate the product.
The DoseCue study was conducted at a retail pharmacy to determine if patient compliance improved when oral-dose medications were dispensed in a DoseCue-equipped container. Thirty-five (35) patients were enrolled and randomized into either a Control or Study Group. All patients used an inactive container for Month 1 (Phase 1) which, unknown to participants, automatically logged date and time of open/close events, after which half were crossed-over to a container which also cued at dose time (Study Group). Remaining patients continued use of the inactive container (Control Group). Twenty-four (24) patients completed the study.
"We know the costs of non-compliance are high," said Burrows. "With DoseCue, there's n
'/>"/>
| SOURCE DoseCue, LLC Copyright©2009 PR Newswire. All rights reserved |